US Regulatory Affairs Certification (RAC) Practice Exam

These questions are part of the practice quiz. Start practicing

• What is a drug product defined as?
• Which of the following describes Class III devices?
• What is a significant requirement for drugs in an ANDA?
• What does the abbreviation NDA stand for?
• Which of the following is the Center for Drug Evaluation and Research abbreviated as?
• What is contained in a Device Master Record (DMR)?
• What is required during Post Marketing Surveillance (PMS)?
• What did the FDA Modernization Act of 1997 (FDAMA) allow clinical study sponsors to do?
• What defines pharmaceutical equivalents?
• What does an Annual Report to the FDA typically include?
• Which term does NOT include soap in its definition according to cosmetic regulations?
• What was the primary purpose of the 1992 Medical Devices Amendments?
• What is the primary function of a Special Protocol Assessment (SPA)?
• What does 21 CFR 207 regulate?
• What is a key principle of Good Laboratory Practice (GLP)?
• Which module of the CTD contains Quality documentation?
• What innovative process is described in 21 CFR 314 Subpart H?
• What is generally indicated by a clinical hold?
• Which act establishes federal requirements for the privacy of health information?
• What regulatory body is governed by 21 CFR 56?
• What term is used for minor violations leading to firm-initiated product corrections?
• What does the "regional admin information" refer to in the context of the CTD?
• What does UADE stand for?
• What does "Commercial Distribution" refer to?
• In regulatory affairs, what does an Institutional Review Board (IRB) primarily assess?
• Which part outlines the requirements for labeling and good manufacturing practices?
• Combination products may include which of the following?
• Labeling, as defined in regulatory affairs, includes which of the following?
• Which regulatory submission does 21 CFR 314 primarily address?
• What does CTD stand for in regulatory submission?
• Under which act can a biological product be demonstrated to be "biosimilar"?
• What was a key feature of the Medical Device User Fee and Modernization Act?
• What is a primary focus of the Declaration of Helsinki?
• Which Act emphasizes substantial equivalence for marketing applications of devices?
• Cosmetics are defined as articles intended for which of the following purposes?
• Which part of the regulations is focused on medical devices?
• What type of reports are included in Module 5 of the CTD?
• What does 21 CFR 50 aim to protect?
• Which is a key feature of the Prescription Drug User Fee Act?
• What is the primary purpose of an Advisory Committee for the FDA?
• Which of the following is not an option available to an applicant if a device is deemed NSE?
• What is the purpose of the FDA's Fast Track program?
• What is the purpose of Module 2 in the CTD?
• What does 21 CFR parts 1-100 address?
• What does the Accelerated Approval pathway allow for?
• What is a market withdrawal in the context of FDA regulations?
• What does the Office of Combination Products (OCP) oversee?
• According to 21 CFR 807, what must manufacturers and initial distributors of medical devices do?
• What is the primary benefit of the 180-day exclusivity for ANDA applicants?
• What are 21 CFR parts 200s primarily concerned with?
• Which of the following is NOT a responsibility under Good Clinical Practice (GCP)?
• What does the term 'ADME' in pharmacokinetics stand for?
• How long is the typical waiting period for a Type B meeting after a request?
• What does the acronym "GCP" stand for in the context of clinical research regulations?
• According to regulations, what defines a drug?
• What aspect of the Hatch-Waxman Act supports generic drug development?
• What is the purpose of guidance documents published by the FDA?
• What does the expiration date on a product label signify?
• What type of meeting is typically needed to address a dispute in product development?
• What does a Class I Recall imply about a device?
• Which type of drugs are referred to as Orphan Drugs?
• What distinguishes a Class II device from a Class I device?
• What is the purpose of Humanitarian Use Devices as per 21 CFR 814 Subpart H?
• What does NSE indicate regarding a device submitted for evaluation?
• What is the main purpose of conducting a safety review within the 30-day hold period?
• What do Post Marketing Requirements (PMR) require sponsors to conduct?
• What do 21 CFR parts 800s regulate?
• What distinguishes a Type A meeting from other meeting types?
• What is an excipient in a drug formulation?
• Which FDA aspect does the term "guidance" primarily relate to?
• What is the purpose of the Orange Book published by the FDA?
• What is a Modular PMA?
• Which section covers administrative issues related to human subjects?
• What is the purpose of the eCTD?
• What does eCTD stand for?
• In what context does a Type C meeting typically occur?
• What type of product does a Suitability Petition pertain to?
• What does GLP stand for in regulatory affairs?
• What does OCP represent in the context of the FDA?
• Which regulation pertains to the establishment registration and device listing for manufacturers?
• What does GCP stand for in clinical trials?
• What is typically required for Class III devices before market approval?
• What is the purpose of the De Novo Process in FDA regulations?
• What is the main objective of the Product Development Process (PDP)?
• What does BLA stand for in the context of regulatory affairs?
• What is one of the primary functions of the Food and Drug Administration Safety and Innovation Act of 2012 (FDASIA)?
• What requirement does FDAAA place upon direct-to-consumer advertisements?
• Which section outlines the criteria for Investigational Device Exemptions?
• What does MAF stand for in the regulatory environment?
• Which of the following statements accurately describes Quality System Regulations (QSR)?
• Which of the following describes a significant risk device?
• What is the focus of Good Manufacturing Practice (GMP) regulations?
• What is an example of a significant risk that leads to a device being classified as banned?
• Which act provided FDA authority to require pediatric studies of drugs?
• What regulatory framework must medical device manufacturers comply with according to establishment listings?
• What is the purpose of a Certificate to Foreign Government?
• Which center is responsible for evaluating biologics?
• What type of market exclusivity does the Orphan Drug Act offer after FDA approval?
• What does NSR stand for in regulatory terms?
• Which classification is given to products that are incorrectly labeled?
• Which center is focused on regulating devices and radiological health?
• What governs ethical principles in medical research involving human subjects?
• What does pharmacodynamics study?
• What is the purpose of a Type B meeting?
• Which organization developed the CTD framework?
• In the context of FDA regulations, what is defined under 21 CFR 316?
• What does the Common Rule ensure regarding research protocols?
• What does 21 CFR 1270 regulate?
• What is a Target Product Profile (TPP)?
• What does IDE stand for in the context of regulatory affairs?
• What is the role of the Center for Devices and Radiological Health?
• What is the main focus of clinical protocols for phase 3 trials under the SPA?
• How many modules is the CTD divided into?
• What is the definition of a label in regulatory terms?
• What does CFR stand for in regulatory affairs?
• What does PREA stand for?
• What contribution did MDUFA III of 2012 make to the regulatory process?
• What does a Pre-Sub Meeting provide to applicants?
• Why are Phase III trials considered crucial for new drug applications?
• What does MDUFA stand for?
• What does a Generic Drug refer to in the context of regulatory affairs?
• What does pharmacokinetics (PK) study?
• What type of changes does the CBE-30 submission report to the FDA?
• What does IVD stand for in the regulatory context?
• What does the acronym ADME stand for in pharmacology?
• What type of changes does a Real Time PMA Supplement address?
• What main aspect does the FDA Modernization Act enhance for drug studies?
• Which class of device is considered low-risk and requires general controls?
• What kind of subjects are typically examined in Phase I trials?
• Which aspect is addressed by 21 CFR 54?
• What type of information is typically included in a Device Master File?
• What does bioequivalence refer to in pharmaceuticals?
• What is the main focus of Phase I clinical trials?
• What does QSR stand for in regulatory affairs?
• What is the Hatch-Waxman Act primarily known for?
• Which legislative act primarily affects user fees in drug regulation?
• What distinguishes a Traditional PMA from other submission methods?
• Which module would contain Non-Clinical Study Reports?
• What distinguishes a 505(b)(2) application from a standard NDA?
• What does ANDA stand for in the context of drug applications?
• What is the primary purpose of Phase III clinical trials?
• What is a characteristic of the drugs listed in the Orange Book?
• How many subjects are typically involved in Phase II clinical trials?
• What is the focus of 21 CFR parts 700s?
• What is one of the conditions for drugs to qualify under the Fast Track designation?
• What is the processing time for an Abbreviated 510(k) submission?
• What does PDUFA stand for?
• Which factors determine the expiration period of a product?
• In which scenario would a 180-day exclusivity be most beneficial?
• What document might be submitted to provide detailed confidential information on drug manufacturing?
• What is the role of Humanitarian Use Devices under HDE?
• Which of the following is NOT considered a biologic?
• What is the primary focus of 21 CFR 1271?
• What does a consent form inform potential subjects about?
• What does the 510(k) clearance process primarily demonstrate?
• What is PMA an acronym for in regulatory affairs?
• Which meeting type is defined as any meeting other than Type A or Type B?
• What is the focus of 21 CFR 862-892?
• What are GMP regulations focused on?
• What is meant by Component in the context of drug and device manufacturing?
• What must generally be established to demonstrate that a biosimilar is "highly similar" to an existing product?
• What is a Drug Master File (DMF) used for?
• What are Phase IV trials specifically designed to support?
• What is required by the Pediatric Rule concerning drug products?
• In which regulation would you find guidelines pertaining to drugs intended for animal use?
• Which FDA review category includes drugs with faster review times compared to standard applications?
• 21 CFR parts 700s regulates which of the following?
• What is required of an ANDA regarding bioequivalence?
• What does it mean when a drug is marked as "Approved" by the FDA?
• What is a Suitability Petition?
• 21 CFR parts 300s is related to which category of products?
• What is one characteristic of an active ingredient in bioequivalence assessment?
• Which of the following describes a banned device according to FDA regulations?
• What is a key component of labeling required by the FDA?
• Which document provides the production history of a medical device?
• What is covered under 21 CFR parts 600s?
• What does the Design History File (DHF) contain?
• What was the primary purpose of the Nuremberg Code created in 1947?
• What is the intent of a device's Complaint definition?
• What significant change was made by PDUFA V, reauthorized by FDASIA?
• What does DMEPA stand for?
• What is the purpose of the MAUDE database?
• What is the purpose of 21 CFR 312?
• What is the primary purpose of 21 CFR 814?
• Which of the following defines a Complaint?
• What does pharmacovigilance primarily involve?
• What is the Primary Mode of Action (PMOA) used for in combination products?
• What does the Product Development Process (PDP) primarily merge?
• Which document outlines a finished device’s design specifications?
• 21 CFR 312 Subpart E addresses drugs intended to treat which type of conditions?
• What does a Special 510(k) application primarily address?
• 21 CFR 312 is critical for which aspect of drug development?
• Which of the following would qualify as a biologic according to FDA definitions?
• What signifies a device’s classification under the De Novo process?
• What triggers a field alert report according to FDA regulations?
• Which federal regulation section primarily deals with the financial interests of clinical investigators?
• What benefit does the Orphan Drug Act of 1983 provide to developers?
• A patient registry may be considered a part of which controls for certain devices?
• What is the purpose of an Emergency Use IND?
• What is the primary focus of 21 CFR 814 Subpart H?
• Which phase of clinical trials involves the largest number of subjects?
• What role does the Division of Medication Error Prevention and Analysis (DMEPA) play?
• What does the 30-day hold refer to in the context of IND submissions?
• What does "grandfathered" refer to in regulatory terms?
• What is indicated by a Complete Response (CR) Letter from the FDA?
• What distinguishes a Traditional 510(k) from a Special 510(k)?
• What does FOIA stand for?
• Which group of patients must be considered under the Pediatric Rule?
• Which type of application allows for drug approval based on investigations not conducted by the applicant?
• What is the focus of an Investigational New Drug (IND) application?
• What is a requirement for Class II devices to ensure safety and effectiveness?
• What does NDA stand for?
• What is the main characteristic of Phase IV studies?
• What does Module 4 of the CTD focus on?
• What does substantial equivalence establish for a new device?
• What is typically included in Module 1 of the CTD?
• What is the definition of an adulterated product according to FDA regulations?
• What is the purpose of a 120-day safety report?
• What does a product Recall entail?
• What is a Clinical Hold?
• What does CBE-30 refer to in the context of submitting changes to the FDA?
• What is the purpose of the clinical evaluation in the PDP process?
• What is the goal of the Streamlined PMA process?
• What is BIMO an acronym for within the context of FDA regulations?
• Which of the following does 21 CFR parts 100s cover?
• What is an essential aspect of the consent form used in clinical trials?
• What characterizes a transitional device?
• What is the aim of the 515 Program Initiative?
• What is the significance of the term "Grandfathered" in relation to regulatory compliance?
• What does HCT/P stand for?
• What category is included under 21 CFR parts 500s?
• What does 21 CFR 807 Subpart E pertain to?
• What is a Humanitarian Device Exemption (HDE)?
• What is a notable requirement of the FDAAA of 2007 regarding clinical trials?
• What does CPSC stand for in regulatory terms?
• In which scenario is a Priority Review granted by the FDA?
• What information is typically included in an action letter from the FDA?
• What is the main purpose of Post Marketing Surveillance (PMS)?
• What is the primary goal of the Biologics Price Competition and Innovation Act?